Symptom Monitoring With Supported Feedback in Advanced Chronic Kidney Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions
Chronic Kidney Disease (Stages 4 and 5)Health Related Quality of Life
Interventions
BEHAVIORAL

Electronic patient-reported outcome measure (ePROM) for symptom monitoring

Patients randomized to the ePROM intervention arm will be asked to complete monthly reporting of their CKD-associated symptoms using an electronic version of the Integrated Patient Outcome Scale (IPOS)-Renal survey. Their responses will be provided in summary form to their nephrology clinicians at regular intervals and prior to any nephrology clinic visits. Clinicians will be provided with guidance on symptom management and will have the option to participate in an informational session on how to interpret patient symptom responses.

Trial Locations (1)

02114

Mass General Brigham, Boston

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Massachusetts General Hospital

OTHER

NCT07186218 - Symptom Monitoring With Supported Feedback in Advanced Chronic Kidney Disease | Biotech Hunter | Biotech Hunter